Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Scholar Rock has achieved success in a drug study for spinal muscular atrophy, potentially setting a new standard for treatment. Judo Bio has debuted with $100 million funding to develop RNA drugs for kidney targets. Intellia has begun late-stage testing of a CRISPR therapy for a rare swelling disease. GSK's Viiv is expanding the supply of an HIV drug in Africa. Biote...